Significant or recent gastrointestinal disorders with diarrhea as a major symptom (e.g. Crohn's disease, malabsorption, or complete blood count [CBC] grade >=  diarrhea of any etiology)
Significant chronic gastrointestinal disorder with diarrhea as a major symptom (e.g., Crohns disease, malabsorption, or grade >=  National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events Version . [CTCAE v..] diarrhea of any etiology at baseline)
Significant chronic gastrointestinal disorder with diarrhea as a major symptom (e.g., Crohn's disease, malabsorption, or grade >=  National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events version . [CTCAE v..] diarrhea of any etiology at baseline)
Significant chronic gastrointestinal disorder with diarrhea as a major symptom (e.g., Crohns disease, malabsorption, or grade >=  [NCI CTCAE v..] diarrhea of any etiology at screening)
Inability to swallow oral medications or a recent acute gastrointestinal disorder with diarrhea e.g., Cohn's disease, malabsorption, or Common Terminology Criteria for Adverse Event (CTCAE) Grade >  diarrhea of any etiology at baseline
Significant acute gastrointestinal disorders with diarrhea as a major symptom e.g., Crohn's disease,malabsorption, or CTCAE Grade ?  diarrhea of any etiology.
Any gastrointestinal disorder with diarrhea as a major symptom, such as Crohns, or pre-existing chronic diarrhea Common Terminology Criteria (CTC) grade >=  of any etiology; included are malabsorption disorders that in the opinion of the study physician may affect absorption of either afatinib or dasatinib
Patients must not have significant gastrointestinal disorders with diarrhea as a major symptom (e.g. Crohns disease, malabsorption, etc)
Significant gastrointestinal disorder with diarrhea as a major symptom (example Crohn's disease, ulcerative colitis) or grade >=  diarrhea of any etiology at baseline; active hepatobiliary disease with the exception of patients with Gilbert's syndrome, asymptomatic gallstones, liver metastases, or stable chronic liver disease as determined by investigator's assessment
Significant chronic gastrointestinal disorder with diarrhea as a major symptom (eg, Crohn's disease, malabsorption, or Grade ? National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events Version . [CTCAE v..] diarrhea of any etiology at baseline)
Significant or recent acute gastrointestinal disorders with diarrhea as a major symptom.
Significant chronic gastrointestinal disorder with diarrhea as a major symptom (e.g., Crohns disease, malabsorption, or grade >=  National Cancer Institute [NCI] Common Terminology Criteria for Adverse Events [CTCAE] v.. diarrhea of any etiology at baseline)
Significant or recent acute gastrointestinal disorders with diarrhea as a major symptom e.g., Crohn's disease, malabsorption, or Common Terminology Criteria for Adverse Events (CTCAE) grade >  diarrhea of any etiology
Significant chronic gastrointestinal disorder with diarrhea as a major symptom (e.g., Crohns disease, malabsorption, or grade >=  diarrhea of any etiology screening)
Participant has significant chronic gastrointestinal disorder with diarrhea as a major symptom (e.g., Crohns disease, malabsorption, or grade >=  [National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version (v.) .] diarrhea of any etiology at screening)
History of gastrointestinal disease with diarrhea as the major symptom.
Significant gastrointestinal disorder with diarrhea as major symptom
Significant or recent acute gastrointestinal disorders with diarrhea as a major symptom e.g. Crohn's disease, ulcerative colitis, malabsorption or Common Toxicity Criteria (CTC) grade >=  diarrhea of any etiology
Significant or recent acute gastrointestinal disorders with diarrhea as a major symptom for example Crohn's disease, malabsorption or Common Terminology Criteria (CTC) grade >=  diarrhea of any etiology
Any gastrointestinal disorder with diarrhea as a major symptom, such as Crohn's, or pre- existing chronic diarrhea CTCAE Grade ?  of any etiology. Included are malabsorption disorders or surgical procedures that in the opinion of the investigator may affect absorption of study drug;
